{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:29:05Z","timestamp":1790944145192,"version":"4.1.0"},"reference-count":30,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>One of the physiologic consequences of excessive UV radiation (UVR) exposure is apoptosis. This critical response serves to eliminate genetically injured cells and arises, in part, from activation of DNA damage and p53 signaling. Other contributory pathways, however, likely exist but have not been fully characterized. In a recent global screen of UVR response genes in melanocytes, we identified the receptor tyrosine kinase EPHA2. Using a combination of genetic and pharmacologic approaches, we set out to investigate the upstream regulation of EphA2 by UVR and the functional consequences of this effect. We found that the UVR-associated increase in EphA2 occurs in melanocytes, keratinocytes, and fibroblasts from both human and murine sources. More specifically, UVR effectively up-regulated EphA2 individually in p53-null, p63-null, and p73-null murine embryonic fibroblasts (MEF), suggesting that the p53 family of transcription factors is not essential for the observed effect. However, inhibition of mitogen-activated protein kinase (MAPK) signaling by U0126 and PD98059 significantly reduced the UVR response whereas overexpression of oncogenic NRAS led to an increase in EphA2. These results confirm that UVR induces EphA2 by a p53-independent, but MAPK-dependent, mechanism. In response to UV irradiation, Epha2\u2212\/\u2212 MEFs were highly resistant to UVR-mediated cytotoxicity and apoptosis whereas introduction of EphA2 into both wild-type and p53-null MEFs led to activation of an apoptotic program that can be blocked by caspase-8 inhibition. These functional findings suggest that EphA2 is in fact an essential p53-independent, caspase-8\u2013dependent proapoptotic factor induced by UVR. [Cancer Res 2008;68(6):1691\u20136]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-2372","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T14:04:16Z","timestamp":1205417056000},"page":"1691-1696","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["EphA2 Is an Essential Mediator of UV Radiation\u2013Induced Apoptosis"],"prefix":"10.1158","volume":"68","author":[{"given":"Guoqi","family":"Zhang","sequence":"first","affiliation":[{"name":"1Wellman Center for Photomedicine,"},{"name":"2Department of Dermatology, Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ni","family":"Njauw","sequence":"additional","affiliation":[{"name":"1Wellman Center for Photomedicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Min","family":"Park","sequence":"additional","affiliation":[{"name":"1Wellman Center for Photomedicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Naruse","sequence":"additional","affiliation":[{"name":"4Division of Transgenic Animal Science, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Asano","sequence":"additional","affiliation":[{"name":"4Division of Transgenic Animal Science, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hensin","family":"Tsao","sequence":"additional","affiliation":[{"name":"1Wellman Center for Photomedicine,"},{"name":"2Department of Dermatology, Harvard Medical School, and"},{"name":"3MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,3,13]]},"reference":[{"key":"2022061700413821500_B1","doi-asserted-by":"crossref","unstructured":"Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal\u20082004; 6: 561\u201370.","DOI":"10.1089\/152308604773934314"},{"key":"2022061700413821500_B2","doi-asserted-by":"crossref","unstructured":"Naik E, Michalak EM, Villunger A, Adams JM, Strasser A. Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol\u20082007; 176: 415\u201324.","DOI":"10.1083\/jcb.200608070"},{"key":"2022061700413821500_B3","doi-asserted-by":"crossref","unstructured":"Yang G, Zhang G, Pittelkow MR, Ramoni M, Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J Invest Dermatol\u20082006; 126: 2490\u2013506.","DOI":"10.1038\/sj.jid.5700470"},{"key":"2022061700413821500_B4","doi-asserted-by":"crossref","unstructured":"Gale NW, Yancopoulos GD. Ephrins and their receptors: a repulsive topic? Cell Tissue Res\u20081997; 290: 227\u201341.","DOI":"10.1007\/s004410050927"},{"key":"2022061700413821500_B5","doi-asserted-by":"crossref","unstructured":"Easty DJ, Hill SP, Hsu MY, et al. Up-regulation of ephrin-A1 during melanoma progression. Int J Cancer\u20081999; 84: 494\u2013501.","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.0.CO;2-O"},{"key":"2022061700413821500_B6","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene\u20082003; 22: 3070\u20135.","DOI":"10.1038\/sj.onc.1206447"},{"key":"2022061700413821500_B7","doi-asserted-by":"crossref","unstructured":"Kinch MS, Carles-Kinch K. Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis\u20082003; 20: 59\u201368.","DOI":"10.1023\/A:1022546620495"},{"key":"2022061700413821500_B8","doi-asserted-by":"crossref","unstructured":"Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS. Differential regulation of EphA2 in normal and malignant cells. Am J Pathol\u20082003; 162: 1037\u201342.","DOI":"10.1016\/S0002-9440(10)63899-0"},{"key":"2022061700413821500_B9","doi-asserted-by":"crossref","unstructured":"Tsao H, Goel V, Wu H, Yang G, Haluska FG. Genetic interaction between NRAS and BRAF mutations and PTEN\/MMAC1 inactivation in melanoma. J Invest Dermatol\u20082004; 122: 337\u201341.","DOI":"10.1046\/j.0022-202X.2004.22243.x"},{"key":"2022061700413821500_B10","doi-asserted-by":"crossref","unstructured":"Naruse-Nakajima C, Asano M, Iwakura Y. Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1. Mech Dev\u20082001; 102: 95\u2013105.","DOI":"10.1016\/S0925-4773(01)00290-8"},{"key":"2022061700413821500_B11","doi-asserted-by":"crossref","unstructured":"Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A\u20081991; 88: 10124\u20138.","DOI":"10.1073\/pnas.88.22.10124"},{"key":"2022061700413821500_B12","doi-asserted-by":"crossref","unstructured":"Dohn M, Jiang J, Chen X. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene\u20082001; 20: 6503\u201315.","DOI":"10.1038\/sj.onc.1204816"},{"key":"2022061700413821500_B13","doi-asserted-by":"crossref","unstructured":"Macrae M, Neve RM, Rodriguez-Viciana P, et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell\u20082005; 8: 111\u20138.","DOI":"10.1016\/j.ccr.2005.07.005"},{"key":"2022061700413821500_B14","doi-asserted-by":"crossref","unstructured":"Jin YJ, Wang J, Qiao C, Hei TK, Brandt-Rauf PW, Yin Y. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis. Mol Cancer Res\u20082006; 4: 769\u201378.","DOI":"10.1158\/1541-7786.MCR-06-0178"},{"key":"2022061700413821500_B15","doi-asserted-by":"crossref","unstructured":"Xu H, Tian W, Lindsley JN, et al. EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo. Am J Physiol Renal Physiol\u20082005; 288: F855\u201366.","DOI":"10.1152\/ajprenal.00347.2004"},{"key":"2022061700413821500_B16","doi-asserted-by":"crossref","unstructured":"Baldwin C, Chen ZW, Bedirian A, et al. Up-regulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Am J Physiol Renal Physiol\u20082006; 291: F960\u201371.","DOI":"10.1152\/ajprenal.00020.2006"},{"key":"2022061700413821500_B17","doi-asserted-by":"crossref","unstructured":"Hafner C, Becker B, Landthaler M, Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and down-regulation of EphA1 in nonmelanoma skin cancer. Mod Pathol\u20082006; 19: 1369\u201377.","DOI":"10.1038\/modpathol.3800660"},{"key":"2022061700413821500_B18","doi-asserted-by":"crossref","unstructured":"Guo H, Miao H, Gerber L, et al. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res\u20082006; 66: 7050\u20138.","DOI":"10.1158\/0008-5472.CAN-06-0004"},{"key":"2022061700413821500_B19","unstructured":"Easty DJ, Guthrie BA, Maung K, et al. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res\u20081995; 55: 2528\u201332."},{"key":"2022061700413821500_B20","doi-asserted-by":"crossref","unstructured":"Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci\u20082003; 995: 151\u201361.","DOI":"10.1111\/j.1749-6632.2003.tb03218.x"},{"key":"2022061700413821500_B21","doi-asserted-by":"crossref","unstructured":"Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther\u20082006; 5: 228\u201333.","DOI":"10.4161\/cbt.5.2.2510"},{"key":"2022061700413821500_B22","doi-asserted-by":"crossref","unstructured":"Brantley DM, Cheng N, Thompson EJ, et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene\u20082002; 21: 7011\u201326.","DOI":"10.1038\/sj.onc.1205679"},{"key":"2022061700413821500_B23","doi-asserted-by":"crossref","unstructured":"Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene\u20082000; 19: 6043\u201352.","DOI":"10.1038\/sj.onc.1204004"},{"key":"2022061700413821500_B24","doi-asserted-by":"crossref","unstructured":"Han L, Dong Z, Qiao Y, et al. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. Gynecol Oncol\u20082005; 99: 278\u201386.","DOI":"10.1016\/j.ygyno.2005.06.036"},{"key":"2022061700413821500_B25","doi-asserted-by":"crossref","unstructured":"Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer\u20082006; 6: 144.","DOI":"10.1186\/1471-2407-6-144"},{"key":"2022061700413821500_B26","doi-asserted-by":"crossref","unstructured":"Herrem CJ, Tatsumi T, Olson KS, et al. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma. Clin Cancer Res\u20082005; 11: 226\u201331.","DOI":"10.1158\/1078-0432.226.11.1"},{"key":"2022061700413821500_B27","doi-asserted-by":"crossref","unstructured":"Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer\u20082003; 103: 657\u201363.","DOI":"10.1002\/ijc.10860"},{"key":"2022061700413821500_B28","doi-asserted-by":"crossref","unstructured":"Landen CN, Kinch MS, Sood AK. EphA2 as a target for ovarian cancer therapy. Expert Opin Ther Targets\u20082005; 9: 1179\u201387.","DOI":"10.1517\/14728222.9.6.1179"},{"key":"2022061700413821500_B29","doi-asserted-by":"crossref","unstructured":"Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene\u20081999; 18: 2967\u201387.","DOI":"10.1038\/sj.onc.1202727"},{"key":"2022061700413821500_B30","doi-asserted-by":"crossref","unstructured":"Cox AD, Der CJ. The dark side of Ras: regulation of apoptosis. Oncogene\u20082003; 22: 8999\u20139006.","DOI":"10.1038\/sj.onc.1207111"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/6\/1691\/2601224\/1691.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/6\/1691\/2601224\/1691.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:54:53Z","timestamp":1684274093000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/6\/1691\/543054\/EphA2-Is-an-Essential-Mediator-of-UV-Radiation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,13]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2008,3,13]]},"published-print":{"date-parts":[[2008,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-2372","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6497306","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497306.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22374035.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374035","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,13]]}}}